The company said it raised £6.1 million from its initial public offering, short of its indication of £10 million when the IPO was announced in September.
“The downturn is affecting companies across the board,” said Chris Sullivan, director of strategic alliances of Celoxica, in a telephone interview. “Unfortunately it’s the (stock) market that sets the value of companies.”
Still, regardless of the stock-market view, Sullivan said the company itself is optimistic about the growth of its market in semiconductor design in 2006. “That would work in our favour,” he said. He also said the company is glad to be listed on AIM as it foresees the advantage of being more visible to the public, which may translate to more confidence in the company from investors.
Celoxica shares traded at 35 pence as of 13:27 Friday, up one penny from Thursday’s close and up from the IPO price of 31.25 pence a share.
The money that was being raised would go into product development, which will focus on intellectual property of its software.
Investors in Celoxica include venture capital firms Advent, which is the largest shareholder with about 25 percent of the company, Cazenove, Quester and industry investors Intel Capital, Xilinx, Wind River and Creative.
Celoxica sells software and electronic boards for designing and testing chips for equipment used in defence, consumer electronics, and cars. Its customers include Lockheed Martin, Toshiba, Canon, BAE Systems, and Fujitsu.
Its specialty, called Electronic System Level design, permits electronics engineers to design components more efficiently and quickly than previously possible. That’s important for increasingly complicated products that combine digital images, signal processing, multimedia and communications. According to a report by Gartner Group, a market-research firm, ESL will become a major driver of growth for the broader electronic-design automation market, and could be worth as much as $1.6 billion by 2009.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.